Palifermin Injection Shortage
Last Updated: December 27, 2023
Status: Current
Products Affected - Description
-
- Kepivance lyophilized powder for injection, Swedish Orphan Biovitrum AB, 6.25 mg vial, 3 count, NDC 66658-0112-03 - discontinued
- Kepivance lyophilized powder for injection, Swedish Orphan Biovitrum AB, 6.25 mg vial, 6 count, NDC 66658-0112-06 - discontinued
Reason for the Shortage
-
- Swedish Orphan Biovitrum AB has Kepivance on shortage due to regulatory delays. The company discontinued the 6.25 mg strength in October 2023.
Available Products
-
- Kepivance lyophilized powder for injection, Swedish Orphan Biovitrum AB, 5.16 mg vial, 3 count, NDC 66658-0113-03
- Kepivance lyophilized powder for injection, Swedish Orphan Biovitrum AB, 5.16 mg vial, 6 count, NDC 66658-0113-06
Estimated Resupply Dates
-
- Swedish Orphan Biovitrum AB has Kepivance 5.16 mg vials in 3 count and 6 count available.
Updated
Updated December 27, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 27, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.